138 related articles for article (PubMed ID: 21804585)
1. Trial watch: Nalmefene reduces alcohol use in phase III trial.
Nat Rev Drug Discov; 2011 Aug; 10(8):566. PubMed ID: 21804585
[No Abstract] [Full Text] [Related]
2. Bad medicine: nalmefene in alcohol misuse.
Spence D
BMJ; 2014 Feb; 348():g1531. PubMed ID: 24531208
[No Abstract] [Full Text] [Related]
3. Nalmefene for alcohol dependence.
Harv Ment Health Lett; 2000 Mar; 16(9):7. PubMed ID: 10677202
[No Abstract] [Full Text] [Related]
4. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-analysis - Comment to Naudet.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Nov; 49(6):261-262. PubMed ID: 27388713
[No Abstract] [Full Text] [Related]
5. Opioid Receptor Antagonists in the Treatment of Alcoholism.
Serecigni JG
Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
[TBL] [Abstract][Full Text] [Related]
6. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Is there a Spin?
Naudet F
Pharmacopsychiatry; 2016 Nov; 49(6):260-261. PubMed ID: 27388712
[No Abstract] [Full Text] [Related]
7. Naltrexone in alcohol dependence.
Hartmann PM
Am Fam Physician; 1997 Apr; 55(5):1877-9, 1883-4. PubMed ID: 9105212
[TBL] [Abstract][Full Text] [Related]
8. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
Soyka M
Expert Opin Pharmacother; 2016; 17(4):619-26. PubMed ID: 26810044
[TBL] [Abstract][Full Text] [Related]
9. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone and nalmefene: any meaningful difference?
Swift RM
Biol Psychiatry; 2013 Apr; 73(8):700-1. PubMed ID: 23540350
[No Abstract] [Full Text] [Related]
11. Nalmefene for alcohol dependence: a NICE decision?
Naudet F; Fitzgerald N; Braillon A
Lancet Psychiatry; 2016 Dec; 3(12):1104-1105. PubMed ID: 27889007
[No Abstract] [Full Text] [Related]
12. Opioid modulators for alcohol dependence.
Hillemacher T; Heberlein A; Muschler MA; Bleich S; Frieling H
Expert Opin Investig Drugs; 2011 Aug; 20(8):1073-86. PubMed ID: 21651459
[TBL] [Abstract][Full Text] [Related]
13. Opioid antagonists in the treatment of alcohol dependence.
O'Leary G; Borrow J; Weiss RD
Curr Psychiatry Rep; 2001 Dec; 3(6):484-8. PubMed ID: 11707162
[TBL] [Abstract][Full Text] [Related]
14. Drug reduces alcohol craving.
Nurse Pract; 1999 Feb; 24(2):104. PubMed ID: 10048082
[No Abstract] [Full Text] [Related]
15. ▼Nalmefene-time for last orders?
Drug Ther Bull; 2016 Sep; 54(9):97. PubMed ID: 27609425
[No Abstract] [Full Text] [Related]
16. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Nalmefene: Exaggerated Expectations or Fallacy?
Naudet F; Granger B; Braillon A
Alcohol Alcohol; 2016 Sep; 51(5):623-4. PubMed ID: 27261473
[No Abstract] [Full Text] [Related]
18. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism.
Costantini LC; Kleppner SR; McDonough J; Azar MR; Patel R
Int J Pharm; 2004 Sep; 283(1-2):35-44. PubMed ID: 15363499
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.
van den Brink W; Strang J; Gual A; Sørensen P; Jensen TJ; Mann K
Expert Opin Drug Saf; 2015 Apr; 14(4):495-504. PubMed ID: 25652768
[TBL] [Abstract][Full Text] [Related]
20. Nalmefene for the treatment of alcohol dependence: a current update.
Soyka M
Int J Neuropsychopharmacol; 2014 Apr; 17(4):675-84. PubMed ID: 24246244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
